Lacidofil®

Overview

L. rhamnosus Rosell®-11 + L. helveticus Rosell®-52

Diarrhea, Antibiotic-Associated Diarrhea, H. pylori eradication therapy, Atopic Dermatitis

  • Lactose intolerance in children and adults
    • 2B CFU
  • Atopic Dermatitis in children
    • 2B CFU
  • Antibiotic-associated diarrhea in children and in adults
    • from 1B to 12B depending on age
  • Adjunct to physician-supervised therapy in children and adults with Helicobacter pylori infections
    • 4 to 6B CFU
  • Maintain a healthy microflora in pregnant women undergoing antibiotic therapy
    • 4 to 6B CFU

Lacidofil®, a proprietary combination of Lactobacillus rhamnosus Rosell®-11 and Lactobacillus helveticus Rosell®-52, was developed more than 30 years ago by Lallemand Health Solutions to support and maintain the digestive microflora. Both the finished product formulation and the individual strains have been extensively used and researched worldwide over the years.

Scientific reference(s)

Rampengan, N. H., et al. (2010). "Comparison of efficacies between live and killed probiotics in children with lactose malabsorption." Southeast Asian J Trop Med Public Health 41(2): 474-481.

Kocian (1994). "Further Possibilities in the Treatment of Lactose Intolerance: Lactobacilli." Prakticky Lékar 74: 212-214.

Chernyshov, P. V. (2009). "B7-2/CD28 costimulatory pathway in children with atopic dermatitis and its connection with immunoglobulin E, intracellular interleukin-4 and interferon-gamma production by T cells during a 1-month follow-up." J Eur Acad Dermatol Venereol 23(6): 656-659.

Chernyshov, P. V. (2008). "Influence of the treatment on costimulatory mechanisms of immunity in children with atopic dermatitis." ДЕРМАТОЛОГІЯ 3: 29-33.

Chernyshov, P. V. (2007). "Complex tratment of infants with atopic dermatitis." ДЕРМАТОЛОГІЯ 3: 23-26.

Patsera, M. V., et al. (2010). "Administration of probiotic strains Lactobacillus acidophilus R0052 and Lactobacillus rhamnosus R0011 in childen with pulmonary tuberculosis, complicated with antibiotic-associated Clostridium difficile intestinal infection." Zaporozhye Medical Journal 12(3): 30-33.

Aryayev, M. and N. Kononenko (2009). "Prevention of antibiotic-associated diarrhoea in patients with Cystic Fibrosis." Odessa Medical Journal 4(114): 58-62.

Song, H. J., et al. (2010). "Effect of probiotic Lactobacillus (Lacidofil(R) cap) for the prevention of antibiotic-associated diarrhea: a prospective, randomized, double-blind, multicenter study." J Korean Med Sci 25(12): 1784-1791.

Evans, M., et al. (2016). "Effectiveness of Lactobacillus helveticus and Lactobacillus rhamnosus for the management of antibiotic-associated diarrhoea in healthy adults: a randomised, double-blind, placebo-controlled trial." Br J Nutr: 1-10.

Abaturov, A. E. and O. N. Gerasymenko (2014). "Efficiency of Helicobacter pylori eradication in children with chronic gastroduodenitis who receive combined antibacterial and probiotic therapy.   [translated in english]." СОВРЕМЕННАЯ ПЕДИАТРИЯ 2(58).

natejko, O. Z., et al. (2009). "Antibiotics-associated diarrhea as a complication of antihelicobacter therapy in children ".

Ziemniak (2006). "Efficacy of Helicobacter pylori eradication taking into account its resistance to antibiotics." JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY 57(Suppl 3).

Babak, O. (2007). "The use of Lacidofil in treatment of duodenal peptic ulcers associated with H. pylori." News of Medicine and Pharmacy 5: 24-25.

Vdovychenko, V. I., et al. (2008). "Efficiency of quadrotherapy with probiotics in patients by the duodenal peptic ulcer." MEDICINAL REMEDIES / ЛІКАРСЬКІ ЗАСОБИ 5(43): 90-92.

Liskovich V. V., N. I. A., Ganchar E. P., Dembrovskaya S. V. (2010). "Efficiency of Lacidofil-WM for prevention of vaginal disbiosis and antibiotics-associated diarrhea in puerperas after cesarean operation." Gro Regi Clin PeriCenter 63-66

Chayka, О. N. D., Т.Y. Babich, I.Т. Govorukha (2006). "PREVENTION OF DISBACTERIOSIS IN PREGNANT AND WOMEN RECENTLY CONFINED WITH SURGICAL DELIVERY."

Additional info

Therapeutical area(s)

Gastrointestinal tract

Functionality

Atopic dermatitis · Diarrhea · Helicobacter pylori infection

Age/Gender

Adults · Children

Dosage form

ND

CFU/Dose

2 billion(s)
Scroll to Top
Browse companies by type
Brought to you by